Skip to content

Veracyte VCYT Additional Paid-In Capital

Additional Paid-In Capital at other companies

Idexx Laboratories logo
Idexx LaboratoriesIDXX
$1.86B+9.8%
Natera, Inc. logo
Natera, Inc.NTRA
Revvity logo
RevvityRVTY
Labcorp Holdings logo
Labcorp HoldingsLH
Quest Diagnostics logo
Quest DiagnosticsDGX
Danaher logo
DanaherDHR

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapitalCommonStock.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Veracyte's additional paid-in capital?
Veracyte (VCYT) reported additional paid-in capital of $1.7B in Q1 2026.
How has Veracyte's additional paid-in capital changed year-over-year?
Veracyte's additional paid-in capital increased by 2.5% year-over-year, from $1.66B to $1.7B.
What is the long-term trend for Veracyte's additional paid-in capital?
Over 5 years (2020 to 2025), Veracyte's additional paid-in capital has grown at a 19.3% compound annual growth rate (CAGR), from $702.77M to $1.7B.
What does additional paid-in capital mean?
This represents the excess amount paid by investors for common shares over their par value. It is a key component of shareholders' equity that captures the capital raised through equity offerings beyond the nominal value of the stock. It reflects the historical market premium at which the company has issued its shares.